Table 1.
Summary of results.
| Time | Morphine Sulfate Pellet (25 mg, s.c.) | Osmotic Pump (64 mg/mL, 1.0 μL/hour) | Subcutaneous injection (20 mg/kg, twice daily) |
|---|---|---|---|
| Plasma Concentration (ng/mL) | |||
| 24 hours | 2695.3±785.1 $ | 209.7±50.0 | N/A |
| 72 hours | 1039.5±73.5 $ | 57.3±39.1 | N/A |
| 168 hours | 229.5±92.5 $ | 45.8±25.4 | N/A |
| Antinociception (tail-flick latency, sec) | |||
| 24 hours | 6.4±0.6 $,#,* | 2.5±0.2 # | 7.9±0.8 * |
| 72 hours | 4.2±0.5 # | 3.2±0.2 # | 7.1±0.4 * |
| 168 hours | 3.2±0.3 # | 3.5±0.3 # | 5.5±0.2 * |
| Naloxone-precipitated withdrawal (number of jumps) | |||
| 24 hours | 61.4±11.7 * | 72.0±16.6 * | 35.4±5.1 |
| 72 hours | 130.6±21.8 #,* | 107.8±32.2 * | 51.8±12.2 * |
| 168 hours | 154.2±21.1 $,#,* | 84.6±12.6 * | 89.6±12.2 * |
Significance is shown as
p < 0.05 compared to non-morphine-treated controls,
p < 0.05 compared to morphine S.C. injection,
p < 0.05 compared to osmotic pump as determined by a two-way ANOVA with a Student-Newman-Keuls post hoc test.